A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States

Claudio Jeldres, Sara Baillargeon-Gagne, Daniel Liberman, Hendrik Isbarn, Umberto Capitanio, Shahrokh F. Shariat, Maxine Sun, Giovanni Lughezzani, Paul Perrotte, Francesco Montorsi, Markus Graefen, Pierre I. Karakiewicz

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To examine temporal, geographic, socioeconomic, and clinical determinants of cytoreductive nephrectomy (CNT) use in the surveillance, epidemiology, and end results (SEER) database, because CNT is known to improve survival in patients with metastatic renal cell carcinoma (mRCC). Methods: Within the SEER database, we identified 6226 mRCC patients, who were either treated with CNT (n = 2038) or underwent no surgery (n = 4188) between 1989 and 2004. Chi-square and χ2 trend tests, as well as multivariate logistic regression models, were used to assess the effect of age, gender, race, region of residence, and year of surgery on the rate of CNT. Adjustment was made for the size of the primary tumor. Results: The overall rate of CNT was 30.5%. The rate of CNT increased in the most recent year quartile (P

Original languageEnglish
Pages (from-to)837-841
Number of pages5
JournalUrology
Volume74
Issue number4
DOIs
Publication statusPublished - Oct 2009

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States'. Together they form a unique fingerprint.

Cite this